Royce & Associates’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,464,000
Closed -$2.49M 1145
2017
Q1
$2.49M Sell
1,464,000
-1,800
-0.1% -$3.74K 0.02% 791
2016
Q4
$3.08M Sell
1,465,800
-50,000
-3% -$136K 0.02% 708
2016
Q3
$5.08M Sell
1,515,800
-75,000
-5% -$225K 0.03% 587
2016
Q2
$3.55M Buy
1,590,800
+355,100
+29% +$1.15M 0.02% 685
2016
Q1
$3.85M Buy
1,235,700
+275,000
+29% +$711K 0.02% 686
2015
Q4
$2.71M Buy
960,700
+594,100
+162% +$1.9M 0.02% 797
2015
Q3
$1.91M Buy
366,600
+74,300
+25% +$426K 0.01% 878
2015
Q2
$1.99M Buy
+292,300
New +$2.07M 0.01% 932

Other funds holding HLTH

Royce & Associates's HLTH Position: Q2 2017 in Review

Royce & Associates sold out of Nobilis Health Corp. (HLTH) in Q2 2017, closing a stake of 1,464,000 shares — an estimated $2.49M sold.

Royce & Associates first reported a position in HLTH in Q2 2015 and held it in 8 quarters. The position peaked at $5.08M in Q3 2016. 49 funds tracked by Wall St. Rank hold HLTH as of Q2 2017.

  • Royce & Associates reported no remaining Nobilis Health Corp. position as of Q2 2017 after selling out during the quarter.
  • Royce & Associates sold 1,464,000 Nobilis Health Corp. shares in Q2 2017, an estimated $2.49M.
  • Royce & Associates first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 8 quarters.
  • Royce & Associates's Nobilis Health Corp. position peaked at $5.08M in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2017.

Based on Royce & Associates's 13F filing for Q2 2017, filed 7 Aug 2017.